Schedule 13G ownership disclosure
Trevi Therapeutics Inc
Common Shares · CUSIP: 89532M101
Event date: 2025-02-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rosalind Advisors, Inc.
Shares: 1,062,500.00 · Class: 1.2%
- SALAMON STEVEN A J
Shares: 1,062,500.00 · Class: 1.2%
- Aharon Gil
Shares: 1,062,500.00 · Class: 1.2%
- Rosalind Master Fund L.P.
Shares: 1,062,500.00 · Class: 1.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001622627-25-000012
- Form type
- SCHEDULE 13G/A
- Filer
- Rosalind Advisors, Inc.
- CIK
- CIK 1622627
- Filed
- Feb 13, 2025
- Reporting period
- Feb 13, 2025
- Description
- Schedule 13G beneficial ownership